GO:1901363 | heterocyclic compound binding | 15.04% (20/133) | 1.74 | 2e-06 | 0.000221 |
GO:0097159 | organic cyclic compound binding | 15.04% (20/133) | 1.74 | 2e-06 | 0.000221 |
GO:0005488 | binding | 24.06% (32/133) | 1.03 | 5.7e-05 | 0.003999 |
GO:0090304 | nucleic acid metabolic process | 5.26% (7/133) | 2.6 | 0.000168 | 0.008771 |
GO:0000049 | tRNA binding | 1.5% (2/133) | 6.07 | 0.000349 | 0.014604 |
GO:0032553 | ribonucleotide binding | 6.77% (9/133) | 1.82 | 0.001076 | 0.016065 |
GO:0097367 | carbohydrate derivative binding | 6.77% (9/133) | 1.79 | 0.001264 | 0.016505 |
GO:0005524 | ATP binding | 6.02% (8/133) | 1.94 | 0.0012 | 0.016725 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.26% (7/133) | 2.15 | 0.001059 | 0.017034 |
GO:0006364 | rRNA processing | 1.5% (2/133) | 4.8 | 0.002244 | 0.017367 |
GO:0016072 | rRNA metabolic process | 1.5% (2/133) | 4.8 | 0.002244 | 0.017367 |
GO:0030554 | adenyl nucleotide binding | 6.02% (8/133) | 1.85 | 0.001764 | 0.01756 |
GO:0006725 | cellular aromatic compound metabolic process | 5.26% (7/133) | 2.03 | 0.00171 | 0.017869 |
GO:0017076 | purine nucleotide binding | 6.77% (9/133) | 1.83 | 0.001042 | 0.01814 |
GO:0043229 | intracellular organelle | 3.01% (4/133) | 2.93 | 0.00192 | 0.018236 |
GO:1901360 | organic cyclic compound metabolic process | 5.26% (7/133) | 1.97 | 0.002195 | 0.018351 |
GO:0035639 | purine ribonucleoside triphosphate binding | 6.77% (9/133) | 1.9 | 0.000717 | 0.018729 |
GO:0043167 | ion binding | 9.77% (13/133) | 1.36 | 0.001709 | 0.018795 |
GO:0046483 | heterocycle metabolic process | 5.26% (7/133) | 1.98 | 0.002075 | 0.018853 |
GO:0036094 | small molecule binding | 7.52% (10/133) | 1.75 | 0.000814 | 0.018897 |
GO:0043226 | organelle | 3.01% (4/133) | 2.88 | 0.00217 | 0.018898 |
GO:0003676 | nucleic acid binding | 7.52% (10/133) | 1.73 | 0.000905 | 0.018911 |
GO:0016070 | RNA metabolic process | 3.76% (5/133) | 2.42 | 0.002538 | 0.018946 |
GO:0032555 | purine ribonucleotide binding | 6.77% (9/133) | 1.83 | 0.001008 | 0.019148 |
GO:0043168 | anion binding | 6.77% (9/133) | 1.62 | 0.002708 | 0.019515 |
GO:1901265 | nucleoside phosphate binding | 7.52% (10/133) | 1.79 | 0.000654 | 0.01953 |
GO:0000166 | nucleotide binding | 7.52% (10/133) | 1.79 | 0.000654 | 0.01953 |
GO:0032559 | adenyl ribonucleotide binding | 6.02% (8/133) | 1.86 | 0.001706 | 0.019806 |
GO:0008144 | drug binding | 6.02% (8/133) | 1.87 | 0.001621 | 0.019926 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.26% (7/133) | 1.88 | 0.003035 | 0.021145 |
GO:0005634 | nucleus | 2.26% (3/133) | 3.25 | 0.003916 | 0.026399 |
GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0007059 | chromosome segregation | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0018205 | peptidyl-lysine modification | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0000469 | cleavage involved in rRNA processing | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0019238 | cyclohydrolase activity | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0003937 | IMP cyclohydrolase activity | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0005730 | nucleolus | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 0.75% (1/133) | 7.39 | 0.005968 | 0.030423 |
GO:0034470 | ncRNA processing | 1.5% (2/133) | 4.07 | 0.00626 | 0.031152 |
GO:0008064 | regulation of actin polymerization or depolymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0043244 | regulation of protein complex disassembly | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0043254 | regulation of protein complex assembly | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030832 | regulation of actin filament length | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030833 | regulation of actin filament polymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0031333 | negative regulation of protein complex assembly | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0032272 | negative regulation of protein polymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0032535 | regulation of cellular component size | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0032956 | regulation of actin cytoskeleton organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0032970 | regulation of actin filament-based process | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030837 | negative regulation of actin filament polymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030835 | negative regulation of actin filament depolymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0043242 | negative regulation of protein complex disassembly | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030834 | regulation of actin filament depolymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0051016 | barbed-end actin filament capping | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:1902903 | regulation of supramolecular fiber organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:1902904 | negative regulation of supramolecular fiber organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:1901880 | negative regulation of protein depolymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:1901879 | regulation of protein depolymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0030688 | preribosome, small subunit precursor | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0032271 | regulation of protein polymerization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0110053 | regulation of actin filament organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0090066 | regulation of anatomical structure size | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0051693 | actin filament capping | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0051494 | negative regulation of cytoskeleton organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0001522 | pseudouridine synthesis | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0051493 | regulation of cytoskeleton organization | 0.75% (1/133) | 6.39 | 0.011901 | 0.032728 |
GO:0044424 | intracellular part | 4.51% (6/133) | 1.82 | 0.007242 | 0.0352 |
GO:0009451 | RNA modification | 1.5% (2/133) | 3.93 | 0.007552 | 0.035873 |
GO:0006281 | DNA repair | 1.5% (2/133) | 3.48 | 0.013787 | 0.037421 |
GO:0003674 | molecular_function | 33.83% (45/133) | 0.51 | 0.005731 | 0.037429 |
GO:0043227 | membrane-bounded organelle | 2.26% (3/133) | 2.82 | 0.008839 | 0.039306 |
GO:0043231 | intracellular membrane-bounded organelle | 2.26% (3/133) | 2.82 | 0.008839 | 0.039306 |
GO:0140098 | catalytic activity, acting on RNA | 2.26% (3/133) | 2.84 | 0.008502 | 0.039488 |
GO:0033043 | regulation of organelle organization | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0003968 | RNA-directed 5'-3' RNA polymerase activity | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0030145 | manganese ion binding | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0010639 | negative regulation of organelle organization | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0051129 | negative regulation of cellular component organization | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0004017 | adenylate kinase activity | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0019205 | nucleobase-containing compound kinase activity | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0050145 | nucleoside monophosphate kinase activity | 0.75% (1/133) | 5.8 | 0.017799 | 0.041332 |
GO:0009987 | cellular process | 12.03% (16/133) | 0.93 | 0.009932 | 0.043244 |
GO:0044464 | cell part | 5.26% (7/133) | 1.55 | 0.01042 | 0.044446 |
GO:0006974 | cellular response to DNA damage stimulus | 1.5% (2/133) | 3.3 | 0.017507 | 0.045736 |
GO:0051716 | cellular response to stimulus | 1.5% (2/133) | 3.3 | 0.017507 | 0.045736 |
GO:0033554 | cellular response to stress | 1.5% (2/133) | 3.3 | 0.017507 | 0.045736 |
GO:0006259 | DNA metabolic process | 1.5% (2/133) | 3.18 | 0.020543 | 0.047182 |